Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses.
Shchelkunov
S N
SN
State Research Center for Virology and Biotechnology Vector, pos. Kol'tsovo, Novosibirsk Oblast, 630559 Russia.
Nesterov
A E
AE
Ryazankin
I A
IA
Ignat'ev
G M
GM
Sandakhchiev
L S
LS
D016915:AIDS Vaccines; D000818:Animals; D015195:Drug Design; D005818:Genetic Engineering / Q000379:methods; D006678:HIV / Q000276:immunology*; D006509:Hepatitis B / Q000276:immunology*; D006801:Humans; D051379:Mice; D018155:Orthopoxvirus / Q000276:immunology*; D015202:Protein Engineering / Q000379:methods*; D011994:Recombinant Proteins / Q000276:immunology; D014613:Vaccines, Attenuated / Q000096:biosynthesis / Q000145:classification / Q000276:immunology; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; D014765:Viral Vaccines / Q000096:biosynthesis* / Q000145:classification / Q000276:immunology*
D016915:AIDS Vaccines; D011994:Recombinant Proteins; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; D014765:Viral Vaccines